Intravenous iron to treat anaemia following critical care: a multicentre feasibility randomised trial

Background Anaemia is common and associated with poor outcomes in survivors of critical illness. However, the optimal treatment strategy is unclear. Methods We conducted a multicentre, feasibility RCT to compare either a single dose of ferric carboxymaltose 1000 mg i.v. or usual care in patients bei...

Full description

Bibliographic Details
Main Authors:	Shah, A, Chester-Jones, M, Dutton, SJ, Marian, IR, Barber, VS, Griffith, DM, Singleton, J, Wray, K, James, T, Drakesmith, H, Robbins, PA, Frise, MC, Young, JD, Walsh, TS, McKechnie, SR, Stanworth, SJ, Hutton, P, Bashyal, A, Chapman, G, Donovan, K, James, C, Rea, N, Clark, S, Barclay, L, Priestley, K, Hope, D, McCulloch, C, Jacques, N, Bartley, S, Bhachu, P, Black, J, Haines, E, Eldridge, L, Hill, Q, Walden, A, Richards, T
Format:	Journal article
Language:	English
Published:	Elsevier 2021

Intravenous iron to treat anaemia following critical care: a multicentre feasibility randomised trial

Similar Items